Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 81 Carcinoma, Non-Small-Cell Lung 76 Neoplasms 71 Ovarian Neoplasms 68 Neoplasm Metastasis 30 Fallopian Tube Neoplasms 30 Carcinoma, Ovarian Epithelial 29 Lung Neoplasms 26 Unspecified Adult Solid Tumor, Protocol Specific 24 Triple Negative Breast Neoplasms 20 Endometrial Neoplasms 20 Esophageal Neoplasms 18 Stomach Neoplasms 16 Colorectal Neoplasms 14 Squamous Cell Carcinoma of Head and Neck 13 Head and Neck Neoplasms 13 Solid Tumors 12 Small Cell Lung Carcinoma 10 Melanoma 10 Pancreatic Neoplasms 9 Uterine Cervical Neoplasms 8 Prostatic Neoplasms 8 Lymphoma, Non-Hodgkin 8 Lymphoma, Large B-Cell, Diffuse 8 Lymphoma 8 Carcinoma, Renal Cell 8 Carcinoma 8 Brenner Tumor 8 Urinary Bladder Neoplasms 7 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7

Interventions

tremelimumab 1 ixabepilone 1 durvalumab 1 ST 1481 1 Paclitaxel 1 Fulvestrant 1 Docetaxel 1 Axitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Solid Malignancies × Paclitaxel × Clear all

NCT02640755 2019-04-22

14C

AstraZeneca

Phase 1 Completed

4 enrolled 34 charts

Solid Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon ⚡